Hims & Hers Health (NYSE:HIMS) CFO Oluyemi Okupe Sells 18,197 Shares of Stock

Posted by Geri Gentry on Jun 23rd, 2026

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) CFO Oluyemi Okupe sold 18,197 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $34.03, for a total transaction of $619,243.91. Following the transaction, the chief financial officer directly owned 284,321 shares of the company’s stock, valued at $9,675,443.63. This represents a 6.02% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oluyemi Okupe also recently made the following trade(s):

On Monday, May 18th, Oluyemi Okupe sold 7,950 shares of Hims & Hers Health stock. The stock was sold at an average price of $23.64, for a total value of $187,938.00.
On Monday, April 20th, Oluyemi Okupe sold 19,645 shares of Hims & Hers Health stock. The stock was sold at an average price of $29.96, for a total value of $588,564.20.
On Thursday, April 16th, Oluyemi Okupe sold 36,922 shares of Hims & Hers Health stock. The shares were sold at an average price of $25.90, for a total value of $956,279.80.
On Friday, April 17th, Oluyemi Okupe sold 18,005 shares of Hims & Hers Health stock. The shares were sold at an average price of $27.83, for a total value of $501,079.15.
On Monday, April 6th, Oluyemi Okupe sold 3,975 shares of Hims & Hers Health stock. The stock was sold at an average price of $19.98, for a total value of $79,420.50.

Hims & Hers Health Stock Down 1.6%

Shares of NYSE:HIMS traded down $0.54 on Tuesday, hitting $33.00. 12,512,469 shares of the company traded hands, compared to its average volume of 30,262,973. Hims & Hers Health, Inc. has a 52 week low of $13.74 and a 52 week high of $70.43. The company has a quick ratio of 1.56, a current ratio of 1.69 and a debt-to-equity ratio of 2.18. The stock has a 50 day simple moving average of $27.02 and a 200-day simple moving average of $26.54. The company has a market cap of $7.64 billion, a PE ratio of -366.67, a PEG ratio of 50.70 and a beta of 2.37.

Hims & Hers Health (NYSE:HIMS – Get Free Report) last announced its quarterly earnings results on Monday, May 11th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.44). Hims & Hers Health had a positive return on equity of 6.10% and a negative net margin of 0.56%.The firm had revenue of $608.10 million during the quarter, compared to the consensus estimate of $616.84 million. During the same quarter in the previous year, the firm earned $0.20 EPS. The business’s revenue for the quarter was up 3.8% on a year-over-year basis. As a group, research analysts expect that Hims & Hers Health, Inc. will post 0.05 earnings per share for the current year.

Hedge Funds Weigh In On Hims & Hers Health

Institutional investors and hedge funds have recently modified their holdings of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Hims & Hers Health by 23.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 418,699 shares of the company’s stock valued at $12,373,000 after acquiring an additional 78,543 shares during the period. Geneos Wealth Management Inc. bought a new stake in shares of Hims & Hers Health during the 1st quarter valued at about $30,000. EverSource Wealth Advisors LLC increased its position in shares of Hims & Hers Health by 273.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 938 shares of the company’s stock valued at $47,000 after purchasing an additional 687 shares during the last quarter. Amundi increased its position in shares of Hims & Hers Health by 5.3% during the 2nd quarter. Amundi now owns 10,296 shares of the company’s stock valued at $489,000 after purchasing an additional 522 shares during the last quarter. Finally, California Public Employees Retirement System lifted its stake in shares of Hims & Hers Health by 9.5% in the 2nd quarter. California Public Employees Retirement System now owns 338,620 shares of the company’s stock worth $16,880,000 after purchasing an additional 29,471 shares during the period. 63.52% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HIMS has been the topic of several analyst reports. Wall Street Zen cut Hims & Hers Health from a “hold” rating to a “sell” rating in a research report on Saturday, May 9th. Truist Financial upped their price target on Hims & Hers Health from $18.00 to $23.00 and gave the company a “hold” rating in a report on Friday, May 22nd. Zacks Research downgraded Hims & Hers Health from a “hold” rating to a “strong sell” rating in a report on Monday, June 8th. UBS Group set a $23.00 target price on Hims & Hers Health in a research report on Friday, May 22nd. Finally, Canaccord Genuity Group set a $32.00 target price on shares of Hims & Hers Health in a research note on Tuesday, May 12th. Four investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $29.37.

Check Out Our Latest Report on HIMS

About Hims & Hers Health

(Get Free Report)

Hims & Hers Health, Inc is a telehealth platform providing direct-to-consumer personal care products and virtual medical services in the United States. Operating under the Hims & Hers brand, the company offers an integrated digital experience that connects users with licensed healthcare providers, enabling online consultations and prescriptions for a range of conditions. Its telemedicine infrastructure supports both prescription medications and over-the-counter products, with home delivery to patients’ doorsteps.

The company’s product portfolio addresses key areas of men’s and women’s health, including hair loss treatments, sexual wellness therapies, skincare regimens and mental health support.